Uncover key drivers, emerging technologies, and competitive movements shaping the large and small-scale bioprocessing market from 2026–2035 with trusted insights from The Business Research Company
What level of growth is expected in the Large And Small-Scale Bioprocessing Market between 2026 and 2030?
The market size for large and small-scale bioprocessing has experienced swift growth recently. It is projected to expand from $67.66 billion in 2025 to $76.73 billion in 2026, driven by a compound annual growth rate (CAGR) of 13.4%. The historical period’s growth can be attributed to the rise of biopharmaceutical manufacturing, increasing investment in biotechnology R&D, the expansion of fermentation-based production, the growing use of cell culture technologies, and the development of large-scale stainless steel bioreactors.
The large and small-scale bioprocessing market is projected to experience substantial growth over the coming years, reaching $119.99 billion by 2030, driven by an 11.8% compound annual growth rate (CAGR). This anticipated expansion throughout the forecast period stems from factors such as a surging demand for biologics and biosimilars, the increasing embrace of single-use technologies, the advancement of personalized and precision medicine, the broadening of CDMO services, and a heightened emphasis on sustainable bioprocessing practices. Key trends during this period are expected to encompass the growing acceptance of single-use and modular bioprocessing systems, an increasing need for adaptable small-scale bioprocessing within R&D, the expansion of contract biomanufacturing and outsourcing strategies, a heightened emphasis on ensuring process scalability from laboratory to commercial production, and the increasing convergence of upstream and downstream bioprocess workflows.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15845&type=smp
Which Drivers Are Expected To Impact The Large And Small-Scale Bioprocessing Market During The Forecast Period?
The escalating need for biologics is projected to boost the expansion of the large and small-scale bioprocessing market moving forward. Biologics encompass medicinal products derived from living organisms or their constituents, including items like vaccines, blood and blood components, gene therapies, tissues, and recombinant therapeutic proteins. This rising demand for biologics stems from advancements in biotechnology, a deeper understanding of disease mechanisms, and the push for targeted and personalized treatments. Both large-scale and small-scale bioprocessing are indispensable for the successful development and commercialization of biologics. Small-scale bioprocessing is crucial for initial development stages, optimization, and feasibility studies. Conversely, large-scale bioprocessing ensures the efficient, consistent production of biologics in adherence to regulatory standards for commercial distribution. For example, in February 2024, according to the National Library of Medicine, a US-based medical library, the Food and Drug Administration (FDA) approved 55 new drugs in 2023, which included 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), indicating a 50% increase compared to the 37 approvals in 2022. Consequently, the growing demand for biologics is a key driver for the growth of the large and small-scale bioprocessing market.
Which Segments Are Driving Activity In The Large And Small-Scale Bioprocessing Market?
The large and small-scale bioprocessing market covered in this report is segmented –
1) By Product: Bioreactors Or Fermenters, Cell Culture Products, Filtration Assemblies, Bioreactors Accessories, Bags And Containers, Other Products
2) By Mode: In-house, Outsourced
3) By Workflow: Downstream Processing, Fermentation, Upstream Processing
4) By Scale: Industrial Scale, Small Scale
5) By Application: Biopharmaceuticals, Specialty Industrial Chemicals, Environmental Aids
Subsegments:
1) Bioreactors Or Fermenters: Single-Use Bioreactors, Stainless Steel Bioreactors, Glass Bioreactors
2) Cell Culture Products: Cell Culture Media, Sera And Supplements, Reagents
3) Filtration Assemblies: Membrane Filters, Depth Filters, Tangential Flow Filtration Systems
4) Bioreactor Accessories: Spargers, Impellers, Sensors And Probes
5) Bags And Containers: Single-Use Bags, Storage Containers, Transfer Bags
6) Other Products: Mixers, Tubing And Connectors, Sampling Systems
What Upcoming Trends Are Likely To Define The Future Path Of The Large And Small-Scale Bioprocessing Market?
Major companies within the large and small-scale bioprocessing market are concentrating on developing innovative solutions, such as fixed-bed, low-footprint bioreactor controllers, to address the increasing demand for high-productivity, cost-efficient, and scalable viral vector and advanced therapy manufacturing, a need driven by the significant growth in gene therapies, vaccines, and biologics. A fixed-bed, low-footprint bioreactor controller functions as a specialized hardware module capable of managing large-area cell culture in fixed-bed reactors, distinguishing itself from traditional large-scale stirred-tank bioreactors by offering a compact form factor, an intuitive user interface, and optimized fluid handling, thereby avoiding the extensive physical space, high capital cost, and complex infrastructure typically associated with conventional systems. For example, in May 2025, Univercells Technologies SA, a bioprocessing company based in Belgium, launched the scale-X Nitro Controller, specifically designed to operate their 200 m² and 600 m² scale-X Nitro fixed-bed bioreactors. This controller is presented as a compact, wheeled unit with a 1.6 m² footprint, allowing it to easily fit through standard cleanroom doors. It supports both adherent and suspension cell cultures and provides highly intuitive control. The system facilitates rapid scale-up from research and development to commercial manufacturing in approximately 8 months, simultaneously reducing the cost-of-goods by 36–82% compared to traditional adherent processes. By combining high productivity with a simplified, space-saving design, the scale-X Nitro Controller empowers biomanufacturers, particularly CDMOs and vaccine developers, to accelerate their development timelines and reduce the economic barriers for large-scale viral production.
Which Major Industry Participants Are Leading The Large And Small-Scale Bioprocessing Market Growth?
Major companies operating in the large and small-scale bioprocessing market are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Ltd., Eli Lilly and Company, AbbVie Inc., Amgen Inc., Biogen Inc., Regeneron Pharmaceuticals Inc., Genentech Inc., Gilead Sciences Inc., Novo Nordisk A/S, CSL Limited, UCB S.A., Samsung Biologics, WuXi Biologics, Boehringer Ingelheim
Access The Complete Report For Deeper Market Insights:
Which Geographic Areas Are Emerging As Strong Markets For The Large And Small-Scale Bioprocessing Market?
North America was the largest region in the large and small-scale bioprocessing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Large And Small-Scale Bioprocessing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15845&type=smp
Browse Through More Reports Similar to the Global Large And Small-Scale Bioprocessing Market 2026, By The Business Research Company
Bioprocess Technology Market Report 2026
https://www.thebusinessresearchcompany.com/report/bioprocess-technology-global-market-report
Single Use Bioprocessing Market Report 2026
https://www.thebusinessresearchcompany.com/report/single-use-bioprocessing-global-market-report
Bioprocessing Technology Market Report 2026
https://www.thebusinessresearchcompany.com/report/bioprocessing-technology-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model